Dr. Moopen’s Family increases 4% stake for Rs. 460 crore in Aster DM Healthcare
The increase of stake in Aster DM Healthcare is a reiteration of the confidence in the business across geographies
The increase of stake in Aster DM Healthcare is a reiteration of the confidence in the business across geographies
The event witnessed a historic journey of Thalassemics India gracing the theme “LAKSH”
Women of all ages will get round-the-clock access to comprehensive treatment
Integration of modern and traditional medicine to facilitate the illness to wellness journey
ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates
ELL will be the preferred source of supply for some the key Raw Materials to VPPL at "Arm's Length" transaction.
“One Earth, One Health” vision can become a reality only with active global collaboration where countries don’t think of only themselves, but of collective global outcomes
Expands robotics to 20+ specialities
Proposed combination enhances Pfizer’s position as a leading company in oncology
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Subscribe To Our Newsletter & Stay Updated